Virulence gene profiles and population genetic analysis for exploration of pathogenic serogroups of shiga toxin-producing escherichia coli

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4022-4028

  Kobayashi, Naoki ^a   Lee, Ken Ichi ^b   Yamazaki, Akiko ^a   Saito, Shioko ^c   Furukawa, Ichiro ^d   Kono, Tomomi ^e   Maeda, Eriko ^f   Isobe, Junko ^g   Sugita Konishi, Yoshiko ^a,b   Hara Kudo, Yukiko ^a,b  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Akita Research Center for Public Health and Environment   (Japan)

^d KANAGAWA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^e Shiga Pref Inst Pub Hlth E   (Japan)

^f FUKUOKA INSTITUTE OF HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^g TOYAMA INSTITUTE OF HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; EHXA GENE; ESPB GENE; ESPD GENE; ESPP GENE; GENETIC ANALYSIS; GENOTYPE; HUMAN; KATP GENE; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; SAA GENE; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; STCE GENE; STX GENE; SUBA GENE; THA GENE;

ANIMALS; CATTLE; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENETIC VARIATION; GENOTYPE; HUMANS; SEROTYPING; SHIGA-TOXIGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 84889869220     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01598-13     Document Type: Article

References (53)

1. Gyles CL. 2007. Shiga toxin-producing Escherichia coli: an overview. J. Anim. Sci. 85:E45-E62.
2. Griffin PM, Tauxe RV. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13:60-98.
3. Johnson KE, Thorpe CM, Sears CL. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43:1587-1595.
4. Tarr PI, Neill MA. 1996. Perspective: the problem of non-O157:H7 Shiga toxin (verocytotoxin)-producing Escherichia coli. J. Infect. Dis. 174:1136-1139.
5. Mellmann A, Bielaszewska M, Kock R, Friedrich AW, Fruth A, Middendorf B, Harmsen D, Schmidt MA, Karch H. 2008. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg. Infect. Dis. 14:1287-1290.
6. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB. 2003. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxinproducing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J. Clin. Microbiol. 41:4930-4940.
7. Lee K, French NP, Hara-Kudo Y, Iyoda S, Kobayashi H, Sugita-Konishi Y, Tsubone H, Kumagai S. 2011. Multivariate analyses revealed distinctive features differentiating human and cattle isolates of Shiga toxinproducing Escherichia coli O157 in Japan. J. Clin. Microbiol. 49:1495-1500.
8. Jackson MP, Newland JW, Holmes RK, O'Brien AD. 1987. Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. Microb. Pathog. 2:147-153.
9. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL. 1999. Associations between virulence factors of Shiga toxinproducing Escherichia coli and disease in humans. J. Clin. Microbiol. 37: 497-503.
10. Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, Taylor FB. 2003. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr. Nephrol. 18:92-96.
11. Tarr PI, Bilge SS, Vary JC, Jr, Jelacic S, Habeeb RL, Ward TR, Baylor MR, Besser TE. 2000. Iha: a novel Escherichia coli O157:H7 adherenceconferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect. Immun. 68:1400-1407.
12. Paton AW, Srimanote P, Woodrow MC, Paton JC. 2001. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect. Immun. 69:6999-7009.
13. Schmidt H, Beutin L, Karch H. 1995. Molecular analysis of the plasmidencoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63:1055-1061.
14. Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC. 2004. A new family of potent AB5 cytotoxins produced by Shiga toxigenic Escherichia coli. J. Exp. Med. 200:35-46.
15. Boerlin P, Chen S, Colbourne JK, Johnson R, De Grandis S, Gyles C. 1998. Evolution of enterohemorrhagic Escherichia coli hemolysin plasmids and the locus for enterocyte effacement in Shiga toxin-producing E. coli. Infect. Immun. 66:2553-2561.
16. Burland V, Shao Y, Perna NT, Plunkett G, Sofia HJ, Blattner FR. 1998. The completeDNAsequence and analysis of the large virulence plasmid of Escherichia coli O157:H7. Nucleic Acids Res. 26:4196-4204.
17. Brunder W, Schmidt H, Karch H. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol. Microbiol. 24:767-778.
18. Brunder W, Schmidt H, Karch H. 1996. KatP, a novel catalaseperoxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology 142:3305-3315.
19. Grys TE, Siegel MB, Lathem WW, Welch RA. 2005. The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells. Infect. Immun. 73:1295-1303.
20. Lang P, Lefebure T, Wang W, Pavinski Bitar P, Meinersmann RJ, Kaya K, Stanhope MJ. 2010. Expanded multilocus sequence typing and comparative genomic hybridization of Campylobacter coli isolates from multiple hosts. Appl. Environ. Microbiol. 76:1913-1925.
21. Wang G, Clark CG, Rodgers FG. 2002. Detection in Escherichia coli of the genes encoding the major virulence factors, the genes defining the O157:H7 serotype, and components of the type 2 Shiga toxin family by multiplex PCR. J. Clin. Microbiol. 40:3613-3619.
22. Scheutz F, Teel LD, Beutin L, Pierard D, Buvens G, Karch H, Mellmann A, Caprioli A, Tozzoli R, Morabito S, Strockbine NA, Melton-Celsa AR, Sanchez M, Persson S, O'Brien AD. 2012. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J. Clin. Microbiol. 50:2951-2963.
23. Bustamante AV, Sanso AM, Lucchesi PM, Parma AE. 2011. Multiplex PCR assay for the detection of five putative virulence genes encoded in verotoxigenic Escherichia coli plasmids. Curr. Microbiol. 62:1411-1415.
24. Jelacic JK, Damrow T, Chen GS, Jelacic S, Bielaszewska M, Ciol M, Carvalho HM, Melton-Celsa AR, O'Brien AD, Tarr PI. 2003. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J. Infect. Dis. 188:719-729.
25. Kobayashi H, Shimada J, Nakazawa M, Morozumi T, Pohjanvirta T, Pelkonen S, Yamamoto K. 2001. Prevalence and characteristics of Shiga toxin-producing Escherichia coli from healthy cattle in Japan. Appl. Environ. Microbiol. 67:484-489.
26. Schmidt H, Plaschke B, Franke S, Russmann H, Schwarzkopf A, Heesemann J, Karch H. 1994. Differentiation in virulence patterns of Escherichia coli possessing eae genes. Med. Microbiol. Immunol. 183:23-31.
27. Toma C, Martinez Espinosa E, Song T, Miliwebsky E, Chinen I, Iyoda S, Iwanaga M, Rivas M. 2004. Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 42:4937-4946.
28. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics 155:945-959.
29. Jakobsson M, Rosenberg NA. 2007. CLUMPP: a cluster matching and permutation program for dealing with label switching and multimodality in analysis of population structure. Bioinformatics 23:1801-1806.
30. Evanno G, Regnaut S, Goudet J. 2005. Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study. Mol. Ecol. 14:2611-2620.
31. Ethelberg S, Olsen KE, Scheutz F, Jensen C, Schiellerup P, Enberg J, Petersen AM, Olesen B, Gerner-Smidt P, Molbak K. 2004. Virulence factors for hemolytic uremic syndrome, Denmark. Emerg. Infect. Dis. 10:842-847.
32. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
33. Paton JC, Paton AW. 1998. Pathogenesis and diagnosis of Shiga toxinproducing Escherichia coli infections. Clin. Microbiol. Rev. 11:450-479.
34. Jenkins C, Willshaw GA, Evans J, Cheasty T, Chart H, Shaw DJ, Dougan G, Frankel G, Smith HR. 2003. Subtyping of virulence genes in verocytotoxin- producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom. J. Med. Microbiol. 52:941-947.
35. Kresse AU, Rohde M, Guzman CA. 1999. The EspD protein of enterohemorrhagic Escherichia coli is required for the formation of bacterial surface appendages and is incorporated in the cytoplasmic membranes of target cells. Infect. Immun. 67:4834-4842.
36. Mellies JL, Elliott SJ, Sperandio V, Donnenberg MS, Kaper JB. 1999. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol. Microbiol. 33: 296-306.
37. Elliott SJ, Sperandio V, Giron JA, Shin S, Mellies JL, Wainwright L, Hutcheson SW, McDaniel TK, Kaper JB. 2000. The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEEand non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 68:6115-6126.
38. Muller D, Benz I, Liebchen A, Gallitz I, Karch H, Schmidt MA. 2009. Comparative analysis of the locus of enterocyte effacement and its flanking regions. Infect. Immun. 77:3501-3513.
39. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, Kodama T, Abe H, Nakayama K, Kurokawa K, Tobe T, Hattori M, Hayashi T. 2009. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 106:17939-17944.
40. Stigi KA, Macdonald JK, Tellez-Marfin AA, Lofy KH. 2012. Laboratory practices and incidence of non-O157 Shiga toxin-producing Escherichia coli infections. Emerg. Infect. Dis. 18:477-479.
41. Kappeli U, Hachler H, Giezendanner N, Beutin L, Stephan R. 2011. Human infections with non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000-2009. Emerg. Infect. Dis. 17:180-185.
42. Werber D, Fruth A, Liesegang A, Littmann M, Buchholz U, Prager R, Karch H, Breuer T, Tschape H, Ammon A. 2002. A multistate outbreak of Shiga toxin-producing Escherichia coli O26:H11 infections in Germany, detected by molecular subtyping surveillance. J. Infect. Dis. 186:419-422.
43. National Institute of Infectious Diseases. 2013. Enterohemorrhagic Escherichia coli infection in Japan as of April 2013. IASR 34:123-124.
44. European Food Safety Authority. 2008. The community summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in the European Union in 2008. EFSA J. 2010:1496. doi:10.2903/j .efsa.2010.1496.
45. Grad YH, Godfrey P, Cerquiera GC, Mariani-Kurkdjian P, Gouali M, Bingen E, Shea TP, Haas BJ, Griggs A, Young S, Zeng Q, Lipsitch M, Waldor MK, Weill FX, Wortman JR, Hanage WP. 2013. Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogen. mBio 4:e00452-12. doi:10 .1128/mBio.00452-12.
46. Hadler JL, Clogher P, Hurd S, Phan Q, Mandour M, Bemis K, Marcus R. 2011. Ten-year trends and risk factors for non-O157 Shiga toxinproducing Escherichia coli found through Shiga toxin testing, Connecticut, 2000-2009. Clin. Infect. Dis. 53:269-276.
47. Lawrence JG. 2005. Common themes in the genome strategies of pathogens. Curr. Opin. Genet. Dev. 15:584-588.
48. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Muller L, King LA, Rosner B, Buchholz U, Stark K, Krause G, HUS Investigation Team. 2011. Epidemic profile of Shigatoxin-producing Escherichia coli O104:H4 outbreak in Germany. N. Engl. J. Med. 365:1771-1780.
49. Brzuszkiewicz E, Thurmer A, Schuldes J, Leimbach A, Liesegang H, Meyer FD, Boelter J, Petersen H, Gottschalk G, Daniel R. 2011. Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: entero-aggregativehaemorrhagic Escherichia coli (EAHEC). Arch. Microbiol. 193:883-891.
50. Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA. 2008. Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl. Environ. Microbiol. 74:2153-2160.
51. Konczy P, Ziebell K, Mascarenhas M, Choi A, Michaud C, Kropinski AM, Whittam TS, Wickham M, Finlay B, Karmali MA. 2008. Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli. J. Bacteriol. 190:5832-5840.
52. Delannoy S, Beutin L, Fach P. 2013. Discrimination of enterohemorrhagic E. coli (EHEC) from non-EHEC strains based on detection of various combinations of non-LEE-encoded type III effector genes. J. Clin. Microbiol. doi:10.1128/JCM.01471-13.
53. Bugarel M, Beutin L, Fach P. 2010. Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates. Appl. Environ. Microbiol. 76:203-211.